Key result
Neither acetylsalicylic acid nor meloxicam had an inhibitory effect on whole blood platelet aggregation or oral mucosal bleeding time in healthy cats, though ASA decreased thromboxane concentrations.
Why the study?
Does acetylsalicylic acid or meloxicam inhibit whole blood platelet aggregation in healthy cats?
RCT (n=8)
randomized
No
Does acetylsalicylic acid or meloxicam inhibit whole blood platelet aggregation in healthy cats?
In healthy cats, neither aspirin nor meloxicam at studied doses inhibited whole blood platelet aggregation despite aspirin reducing thromboxane concentrations.
Answers are grounded in this paper and cite their sources.
Does not support antiplatelet effects of ASA or meloxicam in healthy cats; leaves open questions on dosing, disease states, and clinical translation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Cathcart et al. (2011) conducted an RCT in Healthy (n=8). Acetylsalicylic acid (ASA) and meloxicam vs. Placebo (0.5 mL of water q 24 h) was evaluated on Whole blood platelet aggregation, thromboxane production, and serotonin release. Neither acetylsalicylic acid nor meloxicam had an inhibitory effect on whole blood platelet aggregation or oral mucosal bleeding time in healthy cats, though ASA decreased thromboxane concentrations.
Synapse has enriched 10 related papers. Consider them for comparative context: